Cathay International Holdings Ltd (CTI)

Back to homepage

Company Description

Cathay International Holdings Ltd, incorporated on January 19, 2001, is an investment holding company and an investor in the growing healthcare sector in the China. The Company through its subsidiaries engaged in healthcare business, hotel operations and private equity investments. The Group operates through Haotian Group, which is engaged in the manufacture, marketing and sale of active ingredients for healthcare products. The Company's Lansen Group, manufactures, markets and sales specialty rheumatic specialty prescription medicines, modern Chinese medicine extracts and generic pharmaceuticals in the People's Republic of China. Lansen Group also engaged in collaborations with other pharmaceutical companies to strengthen and expand its portfolio, in autoimmune related disease area. The Company's subsidiary Botai is engaged in research and product development. The Company's Private equity investment segment explores minority investment opportunities, in both private and public companies with an emphasis on the healthcare segment. The Company's subsidairy The Crowne Plaza Hotel & Suites Landmark Shenzhen is engaged in luxury hotel business in the Lowu district of Shenzhen in the People's Republic of China. It is managed by InterContinental Hotels Group...